New Key Statistics Module, Z-Score and F-Score
OTCPK:TWAPF Key Ratios
| Market Cap $ M | 984.18 |
| Enterprise Value $ M | 2,140.55 |
| P/E(ttm) | 9.11 |
| PE Ratio without NRI | 11.19 |
| Forward PE Ratio | 13.58 |
| Price/Book | 0.99 |
| Price/Sales | 0.65 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,574.00 |
| EPS (TTM) $ | 2.29 |
| Beneish M-Score | -2.15 |
| 10-y EBITDA Growth Rate % | 10.00 |
| 5-y EBITDA Growth Rate % | 7.60 |
| y-y EBITDA Growth Rate % | 75.60 |
| EV-to-EBIT | 12.11 |
| EV-to-EBITDA | 10.30 |
| PEG | 1.47 |
| Shares Outstanding M | 49.22 |
| Net Margin (%) | 7.17 |
| Operating Margin % | 8.15 |
| Pre-tax Margin (%) | 10.98 |
| Quick Ratio | 1.46 |
| Current Ratio | 2.72 |
| ROA % (ttm) | 4.22 |
| ROE % (ttm) | 11.55 |
| ROIC % (ttm) | 3.67 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.88 |
TWAPF Number of Guru Trades
TWAPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TWAPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TWAPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TOWA Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:TWAPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers